| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| CHESS ROBERT | Director | C/O NEKTAR THERAPEUTICS, 455 MISSION BAY BLVD SOUTH, SAN FRANCISCO | Mark A. Wilson, Attorney-in-Fact | 01 Oct 2025 | 0001227886 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NKTR | Stock Option | Award | $0 | +8,000 | $0.000000 | 8,000 | 30 Sep 2025 | Common Stock | 8,000 | $56.90 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | This stock option vests in substantially equal monthly installments over the one-year period beginning on September 30, 2025. |